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IN THE UNITED STATES, THREE DIFFERENT AGENCIES HAVE REGULATORY JURISDICTION OVER 
GENETICALLY ENGINEERED (GE) ORGANISMS: THE U.S. DEPARTMENT OF AGRICULTURE, THE FOOD 
AND DRUG ADMINISTRATION, AND THE ENVIRONMENTAL PROTECTION AGENCY.  
 
In 1986, the U.S. government developed its ʺCoordinated 
Framework for Regulation of Biotechnology,ʺ which outlined 
how the regulatory responsibilities would be divided among 
the three agencies, based largely on the existing regulatory 
framework.  The jurisdictions of each agency are described in 
detail below. 
 
U.S. Department of Agriculture (USDA) 
 
The USDAʹs Animal and Plant Health Inspection Service 
(APHIS) is responsible for most issues related to safety of the 
environmental release of genetically engineered organisms 
and their impacts on agriculture. 
   The traditional mandate of APHIS within the U.S. Depart-
ment of Agriculture has been to monitor and prevent the 
spread of plant and animal diseases, particularly those of 
importance to agriculture.  Also within the purview of APHIS 
is the control of weedy ʺinvasiveʺ species (like the Kudzu vines 
of the southeastern U.S.).  APHIS inspects new plants and 
animals brought into the country, quarantines products that 
could spread diseases into the U.S., and helps to control the 
spread of new diseases, invasive plants, animals, and insects.  
Similarly, APHIS has regulatory jurisdiction over the release of 
new GE plants and microorganisms into the environment, and 
eval-uates their potential to become plant pests, weedy 
ʺescapes,ʺ or otherwise cause damage to U.S. agriculture. 
 
Regulated genetically engineered organisms 
In order to move, import, or field test any genetically 
engineered plants or microorganisms, approval of APHIS must 
first be acquired by following the guidelines laid out in U.S. 
Regulation 7 CFR 340.  This is similar to the regulations used to 
monitor the introduction of all other exotic plants and 
microorganisms into the U.S.  Exempt from this regulation are 
organisms grown in laboratories or in sealed greenhouses 
(where escape into the environment is unlikely) and 
genetically engineered organisms which are no longer 
regulated (see next section).  All genetically engineered 
organisms grown outdoors must pass this step first (regulated 
field trials are usually a few acres or less).  
   There are two ways to acquire approval for moving, import-
ing, or field testing GE organisms: notification and release 
permits. 
Notification 
The applicant must notify APHIS in writing, and must 
demonstrate that the GE organism meets certain eligibility 
criteria and that mechanisms for containment of the GE 
organisms are adequate.  The GE organisms cannot be grown 
until APHIS receives and formally acknowledges this 
application.  Most new GE plants go through the notification 
process.  
Release Permits 
Organisms that do not meet the safety criteria of the notifica-
tion process (mainly GE microorganisms and pharmaceutical-
producing plants) must first be granted a release permit before 
field-testing.  Organisms requiring a permit generally undergo 
more careful scrutiny and the approval process is more time-
consuming.  
   Notifications and release permits are only valid for one year-- 
the application process must be repeated every year, even if 
the GE variety is the same.  APHIS officials may also conduct 
inspections of field test sites.  Additionally, the developers of 
regulated GE varieties are required to notify APHIS 
immediately of any accidents or unintended releases of 
regulated organisms. 
 
Deregulation of genetically engineered 
organisms 
After the developer of a GE variety has accumulated several 
years of data from regulated field trials, the developer may 
petition APHIS to allow the new GE variety to be deregulated.  
This means that, as far as APHIS is concerned, the deregulated 
GE variety will be treated no differently than organisms 
developed by conventional means.  Future outdoor plantings, 
import, and interstate movement no longer require notification 
or release permits.  Deregulation is the first important step in 
the eventual marketing of a new GE variety in the U.S.-- the 
new variety must also acquire approval from the FDA and 
EPA (if necessary) before commercial release. 
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   To petition for deregulated status, the developer of a new GE 
plant submits all of its available data to address the potential 
environmental impact and plant pest risk.  APHIS requires 
data to answer the following questions: 
• Does the plant exhibit any plant pathogenic properties  
(i.e., is the plant likely to cause diseases in other plants)? 
• Is the plant more likely to become a weed than a non-GE 
variety? 
• Is the plant likely to increase the weediness of other 
cultivated or wild species it could interbreed with? 
• Could the plant cause any damage to processed 
agricultural commodities? 
• Could the plant cause harm to any other organisms (such 
as bees) that are important to agriculture? 
   After the final submission of a petition document, APHIS 
holds a public comment period, reviews the data (and public 
comments), and then gives its decision. The final decision is 
usually delivered in the form of two documents:  an environ-
mental assessment (EA), which evaluates the potential impact 
of deregulating the variety, and a decision document, which 
considers the potential plant pest risk of the GE crop.  After a 
crop variety has been deregulated, it is treated as any other 
crop variety. 
 
U.S. Food and Drug Administration 
 
If a new GE crop variety will be consumed by humans or 
animals, the U.S. Food and Drug Administration (FDA) is 
responsible for evaluation of its food safety.  
 
Regulatory authority of the FDA  
The FDA determined in 1986 existing regulations were 
adequate to regulate new GE foods.  Coincident with the 
development of the first GE food, the FlavrSavr tomato, the 
FDA published its official interpretation of these regulations in 
the 1992 ʺStatement of Policy: Foods Derived from New Plant 
Varieties.ʺ  This policy report details the existing food safety 
regulations and outlines its procedure for the regulation of 
new GE foods, including several decision-making flowcharts 
to guide developers through the process. 
   Most food safety oversight provided by the FDA takes place 
after the product is on grocery shelves.  The FDA, under 
section 402(a)(1) of the Federal Food, Drug, and Cosmetic Act 
(FFDC 1938), has the authority to regulate or remove foods 
from the market which are found to be ʺadulteratedʺ-- that is, 
containing an added substance that may render the food 
harmful.  The adulteration concept also applies to deliberate 
food additives (but see next section).  Thus the legal 
responsibility to ensure the safety of food products or 
additives falls entirely on the developer of the food.  In prac-
tice, however, developers generally work closely with the FDA 
in the development of new foods, to determine whether the 
FDA would consider a new food adulterated. 
 
Regulation of food additives 
Because of public concern for the safety of an increasing 
number of new food additives, in 1958 the Food Additive 
Amendment was appended to the FFDC Act, requiring pre-
market approval of all food additives.  Developers must 
demonstrate ʺreasonable certainty of no harmʺ of a new food 
additive-- if not, foods containing the additive may be 
considered adulterated under the original act.  The amend-
ment, however, contains an important exception: if an additive 
is ʺgenerally regarded as safeʺ (GRAS), then the additive is 
exempt from formal pre-market safety review.  The intent of 
this exception was to prevent common food additives (like salt, 
pepper, spices, etc) from having to undergo unnecessary safety 
testing.  The determination of GRAS status is not a formal 
process, and the developer may presume an additive to be 
GRAS, only to be contradicted later by the FDA. 
   In the case of GE foods, the FDA has consistently agreed with 
the developers of the new products that the DNA and proteins 
ʺaddedʺ to a conventional food by genetic engineering are 
GRAS.  Arguing that DNA and comparable proteins are 
already widespread in the human diet and present in similar 
concentrations, the additions to GE foods are therefore not 
subject to formal pre-market safety review.  The FDA 
maintains, however, that if new GE foods are developed for 
which GRAS status is unclear-- if, for example, the GE food 
contains a potential allergen or a novel sweetener-- formal 
safety reviews may be required. 
 
Food safety issues considered by the FDA 
During the consultation process, the FDA advises the dev-
eloper of a new GE food to consider several important food 
safety questions.  Some of these topics address the question of 
adulteration (unintended heath consequences), while others 
may affect the GRAS status of GE ʺadditives.ʺ 
Safety of new substances  
Does the protein product created by the engineered gene raise 
food safety issues?  Are there any other new substances 
created in the GE food that may render the food harmful? Does 
the new GE plant contain substances that are not intended for 
widespread human consumption (in the case of a GE plant that 
makes pharmaceutical or industrial compounds)? 
Nutritional value 
Does the new GE food have altered nutritional value (decreas-
ed nutrients or increased anti-nutrients) or increased levels of 
naturally occurring plant toxins? 
 
Allergenicity 
Does the introduced GE protein have an increased risk of 
causing allergic reactions in humans? 
Antibiotic markers 
Could the use of antibiotic resistance genes as ʺselection 
markersʺ affect human or animal health, by potentially 
increasing antibiotic resistance in bacteria? 
Animal feed issues 
Food safety issues might be different for animals than for 
humans, because animals are often fed diets with a high 
concentration of a single plant species (corn, for example) and 
consume plant parts not normally eaten by humans.  Could 
animals be more sensitive to certain food safety risks than 
humans? 
   Although not officially stated in FDA guidelines, the FDA 
uses the idea of substantial equivalence when considering 
the safety and regulatory status of GE foods.  If nutritional and 
toxin content of a new GE food falls within the range of 
concentrations normally observed in conventional varieties, 
and if there are no new health risks associated with the added 
genes and proteins, then the FDA does not regulate GE foods 
any differently than the conventional food. 
 
Labeling of genetically engineered foods 
The FDA requires GE foods to be labeled when there are 
measurable differences in the nutritional qualities of the 
product.  Foods having decreased nutrient content, increased 
antinutrient or natural toxin levels, or increased risk of 
allergenicity must be labeled.  The FDA has consistently ruled 
that they will not require labeling of GE foods simply because 
they are genetically engineered, in the absence of any observed 
nutrition or health differences.  The FDA has, however, 
released guidelines for producers wishing to label GE foods 
voluntarily. 
 
Environmental Protection Agency 
 
Because some GE plants manufacture their own pesticides 
(Bt corn, for example) the U.S. Environmental Protection 
Agency (EPA) is responsible for the safety of the pesticide 
levels in those GE plants which produce them.  
 
Regulation of Biopesticides 
The EPA under the authority of the Federal Insecticide, 
Fungicide, and Rodenticide Act (FIFRA), requires registration 
and licensing of all new pesticides.  Following EPA guidelines, 
the pesticide developer must submit data that demonstrate the 
pesticide will not harm human health or the environment 
when used as labeled.  The data are reviewed by the Office of 
Pesticide Programs (OPP), and the pesticide may not be 
marketed until the OPP approves the productʹs registration. 
   According to current EPA policy, both novel DNA and 
proteins genetically engineered into plants with the intent to 
protect the plant against pests are considered to be ʺplant 
incorporated protectantsʺ (PIPs) and are regulated exactly as 
other pesticides. 
   This regulation includes the pre-market evaluation of both 
environmental and food safety impacts.  The EPA rather than 
the FDA is responsible for the food safety of the PIPs in the 
same way that the EPA evaluates the safety of all other 
pesticides.   Marker genes and other elements not directly 
related to the pesticidal property are considered ʺinert 
ingredientsʺ and also regulated accordingly.   DNA itself, 
although technically classified as a pesticide by EPA legal 
definitions, is exempt from formal safety review, as all food 
contains DNA without any indications of health risk. 
   To date, only two classes of GE plants fall under the EPA 
purview: plants containing Bt toxins (to confer resistance to 
certain insects) and those expressing resistance to viruses.  The 
EPA regulates the pesticide contained within a GE plant in the 
same way it regulates a pesticide applied to a plant, but not 
actually the plant itself. 
   Part of the confusion lies in the relationship between the EPA 
and the FDA. The FDA is responsible for food safety, and the 
EPA is responsible for the safety of the pesticide on human 
health and the environment.  If a plant has been genetically 
engineered to contain a pesticide (a deliberately toxic 
compound), the FDA defers to the EPA to evaluate safety of 
the pesticide.  All other aspects of food safety-- such as altered 
nutritional value, changes in natural toxin levels, etc.-- are still 
the responsibility of the FDA. 
 
Regulation of Companion Herbicides 
The EPA has an additional, indirect role in the regulation of 
GE varieties.  When a GE plant has been engineered to be 
resistant to a specific ʺcompanionʺ herbicide, this implies that 
the conventional varieties of the plant are not normally 
sprayed with the herbicide.  The EPA must then consider the 
health and environmental safety of applying the herbicide to a 
new crop.  If the new application is approved, the EPA must 
establish new tolerances for residues of the herbicide on the 
crop, and adjust herbicide labeling to allow the new crop to be 
sprayed.   For example, when GE cotton resistant to the 
herbicide bromoxynil was first developed, the EPA restricted 
the application of bromoxynil to only 1 percent of all cotton 
acres, but this limit has since been increased to 10 percent.
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If you’d like to learn more about genetic engineering, visit 
the GEO-PIE Project web site at 
 
www.geo-pie.cornell.edu 
 
 
 
 
 
 
 
